{"count": 3, "results": [{"_id": "21105563", "pmid": 21105563, "title": "Metformin and troglitazone in the treatment of female infertility associated with polycystic ovarian syndrome.", "journal": "JNMA J Nepal Med Assoc", "authors": ["Sangraula H", "Paudel KR", "Sharma M"], "date": "2009-10-01T00:00:00Z", "meta_date_publication": "2009 Oct-Dec", "meta_volume": "48", "meta_issue": "176", "meta_pages": "335-9", "score": 50071.39, "text_hl": "@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ and @CHEMICAL_Troglitazone @CHEMICAL_MESH:D000077288 @@@troglitazone@@@ in the treatment of @<m>DISEASE_Infertility_Female</m> @DISEASE_MESH:D007247 @@@female infertility@@@ associated with @DISEASE_Polycystic_Ovary_Syndrome @DISEASE_MESH:D011085 @@@polycystic ovarian syndrome@@@.", "citations": {"NLM": "Sangraula H, Paudel KR, Sharma M. Metformin and troglitazone in the treatment of female infertility associated with polycystic ovarian syndrome. JNMA J Nepal Med Assoc. 2009 Oct-Dec;48(176):335-9. PMID: 21105563", "BibTeX": "@article{21105563, title={Metformin and troglitazone in the treatment of female infertility associated with polycystic ovarian syndrome.}, author={Sangraula H and Paudel KR and Sharma M}, journal={JNMA J Nepal Med Assoc}, volume={48}, number={176}, pages={335-9}}"}}, {"_id": "20222840", "pmid": 20222840, "title": "Insulin sensitiser agents alone and in co-treatment with r-FSH for ovulation induction in PCOS women.", "journal": "Gynecol Endocrinol", "authors": ["Raffone E", "Rizzo P", "Benedetto V"], "date": "2010-04-01T00:00:00Z", "doi": "10.3109/09513590903366996", "meta_date_publication": "2010 Apr", "meta_volume": "26", "meta_issue": "4", "meta_pages": "275-80", "score": 50048.01, "text_hl": "OBJECTIVE: The aim of this study was to compare the effectiveness of @CHEMICAL_Inositol @CHEMICAL_MESH:D007294 @@@myo-inositol@@@ (@CHEMICAL_Inositol @CHEMICAL_MESH:D007294 @@@MYO@@@) and @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@, in monotherapy or in association with recombinant follicle stimulating hormone (r-FSH), in the treatment of @DISEASE_Menstruation_Disturbances @DISEASE_MESH:D008599 @@@menstrual irregularities@@@, chronic @DISEASE_Anovulation @DISEASE_MESH:D000858 @@@anovulation@@@, and @<m>DISEASE_Infertility_Female</m> @DISEASE_MESH:D007247 @@@female infertility@@@ in @SPECIES_9606 @@@patients@@@ with @DISEASE_Polycystic_Ovary_Syndrome @DISEASE_MESH:D011085 @@@polycystic ovary syndrome@@@ (@DISEASE_Polycystic_Ovary_Syndrome @DISEASE_MESH:D011085 @@@PCOS@@@). ", "citations": {"NLM": "Raffone E, Rizzo P, Benedetto V. Insulin sensitiser agents alone and in co-treatment with r-FSH for ovulation induction in PCOS women. Gynecol Endocrinol. 2010 Apr;26(4):275-80. PMID: 20222840", "BibTeX": "@article{20222840, title={Insulin sensitiser agents alone and in co-treatment with r-FSH for ovulation induction in PCOS women.}, author={Raffone E and Rizzo P and Benedetto V}, journal={Gynecol Endocrinol}, volume={26}, number={4}, pages={275-80}}"}}, {"_id": "23262934", "pmid": 23262934, "title": "Prevalence, trends, and patterns of use of antidiabetic medications among pregnant women, 2001-2007.", "journal": "Obstet Gynecol", "authors": ["Lawrence JM", "Andrade SE", "Avalos LA", "Beaton SJ", "Chiu VY", "Davis RL", "Dublin S", "Pawloski PA", "Raebel MA", "Smith DH", "Toh S", "Wang JQ", "Kaplan S", "Amini T", "Hampp C", "Hammad TA", "Scott PE", "Cheetham TC", "Medication Exposure in Pregnancy Risk Evaluation Program (MEPREP) Study Group"], "date": "2013-01-01T00:00:00Z", "doi": "10.1097/aog.0b013e318278ce86", "meta_date_publication": "2013 Jan", "meta_volume": "121", "meta_issue": "1", "meta_pages": "106-14", "score": 50046.266, "text_hl": "Use of antidiabetic medications before pregnancy increased from 0.66% of deliveries in 2001 to 1.66% of deliveries in 2007 (P<.001) because of an increase in @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ use. Most @SPECIES_9606 @@@women@@@ using @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ before pregnancy had a diagnosis code for @DISEASE_Polycystic_Ovary_Syndrome @DISEASE_MESH:D011085 @@@polycystic ovaries@@@ or @<m>DISEASE_Infertility_Female</m> @DISEASE_MESH:D007247 @@@female infertility@@@ (67.2%), whereas only 13.6% had a diagnosis code for @DISEASE_Diabetes_Mellitus @DISEASE_MESH:D003920 @@@diabetes@@@. ", "citations": {"NLM": "Lawrence JM, Andrade SE, Avalos LA, Beaton SJ, Chiu VY, Davis RL, Dublin S, Pawloski PA, Raebel MA, Smith DH, Toh S, Wang JQ, Kaplan S, Amini T, Hampp C, Hammad TA, Scott PE, Cheetham TC, Medication Exposure in Pregnancy Risk Evaluation Program (MEPREP) Study Group. Prevalence, trends, and patterns of use of antidiabetic medications among pregnant women, 2001-2007. Obstet Gynecol. 2013 Jan;121(1):106-14. PMID: 23262934", "BibTeX": "@article{23262934, title={Prevalence, trends, and patterns of use of antidiabetic medications among pregnant women, 2001-2007.}, author={Lawrence JM and Andrade SE and Avalos LA and Beaton SJ and Chiu VY and Davis RL and Dublin S and Pawloski PA and Raebel MA and Smith DH and Toh S and Wang JQ and Kaplan S and Amini T and Hampp C and Hammad TA and Scott PE and Cheetham TC and Medication Exposure in Pregnancy Risk Evaluation Program (MEPREP) Study Group}, journal={Obstet Gynecol}, volume={121}, number={1}, pages={106-14}}"}}]}